A guide to treating gait impairment with prolonged-release fampridine (Fampyra ®) in patients with multiple sclerosis

Conclusions These recommendations will help ensure safer and more efficient prescription practices and easier management of PR-fampridine as treatment for gait impairment in Spanish adults with MS.
Source: Neurologia - Category: Neurology Source Type: research